210 related articles for article (PubMed ID: 21087481)
1. Prospective case-control study of premenopausal serum estradiol and testosterone levels and breast cancer risk.
Dorgan JF; Stanczyk FZ; Kahle LL; Brinton LA
Breast Cancer Res; 2010; 12(6):R98. PubMed ID: 21087481
[TBL] [Abstract][Full Text] [Related]
2. Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC).
Kaaks R; Berrino F; Key T; Rinaldi S; Dossus L; Biessy C; Secreto G; Amiano P; Bingham S; Boeing H; Bueno de Mesquita HB; Chang-Claude J; Clavel-Chapelon F; Fournier A; van Gils CH; Gonzalez CA; Gurrea AB; Critselis E; Khaw KT; Krogh V; Lahmann PH; Nagel G; Olsen A; Onland-Moret NC; Overvad K; Palli D; Panico S; Peeters P; Quirós JR; Roddam A; Thiebaut A; Tjønneland A; Chirlaque MD; Trichopoulou A; Trichopoulos D; Tumino R; Vineis P; Norat T; Ferrari P; Slimani N; Riboli E
J Natl Cancer Inst; 2005 May; 97(10):755-65. PubMed ID: 15900045
[TBL] [Abstract][Full Text] [Related]
3. Premenopausal endogenous steroid hormones and breast cancer risk: results from the Nurses' Health Study II.
Fortner RT; Eliassen AH; Spiegelman D; Willett WC; Barbieri RL; Hankinson SE
Breast Cancer Res; 2013 Mar; 15(2):R19. PubMed ID: 23497468
[TBL] [Abstract][Full Text] [Related]
4. Prediagnostic Circulating Levels of Sex Steroid Hormones and SHBG in Relation to Risk of Ductal Carcinoma
Arthur RS; Xue X; Rohan TE
Cancer Epidemiol Biomarkers Prev; 2020 May; 29(5):1058-1066. PubMed ID: 32127398
[TBL] [Abstract][Full Text] [Related]
5. Premenopausal serum androgens and breast cancer risk: a nested case-control study.
Zeleniuch-Jacquotte A; Afanasyeva Y; Kaaks R; Rinaldi S; Scarmo S; Liu M; Arslan AA; Toniolo P; Shore RE; Koenig KL
Breast Cancer Res; 2012 Feb; 14(1):R32. PubMed ID: 22339988
[TBL] [Abstract][Full Text] [Related]
6. Premenopausal serum sex hormone levels in relation to breast cancer risk, overall and by hormone receptor status - results from the EPIC cohort.
Kaaks R; Tikk K; Sookthai D; Schock H; Johnson T; Tjønneland A; Olsen A; Overvad K; Clavel-Chapelon F; Dossus L; Baglietto L; Rinaldi S; Chajes V; Romieu I; Boeing H; Schütze M; Trichopoulou A; Lagiou P; Trichopoulos D; Palli D; Sieri S; Tumino R; Ricceri F; Mattiello A; Buckland G; Ramón Quirós J; Sánchez MJ; Amiano P; Chirlaque MD; Barricarte A; Bas Bueno-de-Mesquita H; van Gils CH; Peeters PH; Andersson A; Sund M; Weiderpass E; Khaw KT; Wareham N; Key TJ; Travis RC; Merritt MA; Gunter MJ; Riboli E; Lukanova A
Int J Cancer; 2014 Apr; 134(8):1947-57. PubMed ID: 24155248
[TBL] [Abstract][Full Text] [Related]
7. Serum levels of sex hormones and breast cancer risk in premenopausal women: a case-control study (USA).
Sturgeon SR; Potischman N; Malone KE; Dorgan JF; Daling J; Schairer C; Brinton LA
Cancer Causes Control; 2004 Feb; 15(1):45-53. PubMed ID: 14970734
[TBL] [Abstract][Full Text] [Related]
8. Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women.
Eliassen AH; Missmer SA; Tworoger SS; Spiegelman D; Barbieri RL; Dowsett M; Hankinson SE
J Natl Cancer Inst; 2006 Oct; 98(19):1406-15. PubMed ID: 17018787
[TBL] [Abstract][Full Text] [Related]
9. Prospective case-control study of serum mullerian inhibiting substance and breast cancer risk.
Dorgan JF; Stanczyk FZ; Egleston BL; Kahle LL; Shaw CM; Spittle CS; Godwin AK; Brinton LA
J Natl Cancer Inst; 2009 Nov; 101(21):1501-9. PubMed ID: 19820206
[TBL] [Abstract][Full Text] [Related]
10. Determinants of sex hormone-binding globulin blood concentrations in premenopausal and postmenopausal women with different estrogen status. Virgilio-Menopause-Health Group.
Pasquali R; Vicennati V; Bertazzo D; Casimirri F; Pascal G; Tortelli O; Labate AM
Metabolism; 1997 Jan; 46(1):5-9. PubMed ID: 9005961
[TBL] [Abstract][Full Text] [Related]
11. Prospective study of sex hormone levels and risk of prostate cancer.
Gann PH; Hennekens CH; Ma J; Longcope C; Stampfer MJ
J Natl Cancer Inst; 1996 Aug; 88(16):1118-26. PubMed ID: 8757191
[TBL] [Abstract][Full Text] [Related]
12. Plasma sex steroid hormones and breast cancer risk in Chinese women.
Yu H; Shu XO; Shi R; Dai Q; Jin F; Gao YT; Li BD; Zheng W
Int J Cancer; 2003 May; 105(1):92-7. PubMed ID: 12672036
[TBL] [Abstract][Full Text] [Related]
13. Serum sex hormone levels are related to breast cancer risk in postmenopausal women.
Dorgan JF; Longcope C; Stephenson HE; Falk RT; Miller R; Franz C; Kahle L; Campbell WS; Tangrea JA; Schatzkin A
Environ Health Perspect; 1997 Apr; 105 Suppl 3(Suppl 3):583-5. PubMed ID: 9167999
[TBL] [Abstract][Full Text] [Related]
14. Plasma sex hormone concentrations and subsequent risk of breast cancer among women using postmenopausal hormones.
Tworoger SS; Missmer SA; Barbieri RL; Willett WC; Colditz GA; Hankinson SE
J Natl Cancer Inst; 2005 Apr; 97(8):595-602. PubMed ID: 15840882
[TBL] [Abstract][Full Text] [Related]
15. Relation of serum levels of testosterone and dehydroepiandrosterone sulfate to risk of breast cancer in postmenopausal women.
Zeleniuch-Jacquotte A; Bruning PF; Bonfrer JM; Koenig KL; Shore RE; Kim MY; Pasternack BS; Toniolo P
Am J Epidemiol; 1997 Jun; 145(11):1030-8. PubMed ID: 9169912
[TBL] [Abstract][Full Text] [Related]
16. Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies.
Key T; Appleby P; Barnes I; Reeves G;
J Natl Cancer Inst; 2002 Apr; 94(8):606-16. PubMed ID: 11959894
[TBL] [Abstract][Full Text] [Related]
17. Sex hormone measurements using mass spectrometry and sensitive extraction radioimmunoassay and risk of estrogen receptor negative and positive breast cancer: Case control study in UK Collaborative Cancer Trial of Ovarian Cancer Screening (UKCTOCS).
Fourkala EO; Blyuss O; Field H; Gunu R; Ryan A; Barth J; Jacobs I; Zaikin A; Dawnay A; Menon U
Steroids; 2016 Jun; 110():62-69. PubMed ID: 27091764
[TBL] [Abstract][Full Text] [Related]
18. Endogenous sex steroids in premenopausal women and risk of breast cancer: the ORDET cohort.
Schernhammer ES; Sperati F; Razavi P; Agnoli C; Sieri S; Berrino F; Krogh V; Abbagnato C; Grioni S; Blandino G; Schunemann HJ; Muti P
Breast Cancer Res; 2013 Jun; 15(3):R46. PubMed ID: 23777922
[TBL] [Abstract][Full Text] [Related]
19. Sex hormones and risk of breast cancer in premenopausal women: a collaborative reanalysis of individual participant data from seven prospective studies.
; Key TJ; Appleby PN; Reeves GK; Travis RC; Alberg AJ; Barricarte A; Berrino F; Krogh V; Sieri S; Brinton LA; Dorgan JF; Dossus L; Dowsett M; Eliassen AH; Fortner RT; Hankinson SE; Helzlsouer KJ; Hoff man-Bolton J; Comstock GW; Kaaks R; Kahle LL; Muti P; Overvad K; Peeters PH; Riboli E; Rinaldi S; Rollison DE; Stanczyk FZ; Trichopoulos D; Tworoger SS; Vineis P
Lancet Oncol; 2013 Sep; 14(10):1009-19. PubMed ID: 23890780
[TBL] [Abstract][Full Text] [Related]
20. Sex hormone levels and risks of estrogen receptor-negative and estrogen receptor-positive breast cancers.
Farhat GN; Cummings SR; Chlebowski RT; Parimi N; Cauley JA; Rohan TE; Huang AJ; Vitolins M; Hubbell FA; Manson JE; Cochrane BB; Lane DS; Lee JS
J Natl Cancer Inst; 2011 Apr; 103(7):562-70. PubMed ID: 21330633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
